Insulet Management
Management criteria checks 4/4
Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 2.5 years. total yearly compensation is $12.38M, comprised of 6.8% salary and 93.2% bonuses, including company stock and options. directly owns 0.025% of the company’s shares, worth $4.60M. The average tenure of the management team and the board of directors is 2 years and 4.1 years respectively.
Key information
Jim Hollingshead
Chief executive officer
US$12.4m
Total compensation
| CEO salary percentage | 6.8% |
| CEO tenure | 2.5yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly
Dec 18
Here's Why Insulet (NASDAQ:PODD) Has Caught The Eye Of Investors
Dec 04Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20Does This Valuation Of Insulet Corporation (NASDAQ:PODD) Imply Investors Are Overpaying?
Nov 20Returns At Insulet (NASDAQ:PODD) Are On The Way Up
Nov 08Market Participants Recognise Insulet Corporation's (NASDAQ:PODD) Revenues
Oct 15Is There Now An Opportunity In Insulet Corporation (NASDAQ:PODD)?
Oct 03Is Insulet (NASDAQ:PODD) A Risky Investment?
Sep 09Insulet: Turning More Constructive, Valuations Still Stretched
Sep 05Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
Aug 28Additional Considerations Required While Assessing Insulet's (NASDAQ:PODD) Strong Earnings
Aug 16A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Jul 15Insulet Corporation: Insulin Pump Provider Fighting Back After Torrid 2023
Jun 11We Like These Underlying Return On Capital Trends At Insulet (NASDAQ:PODD)
May 26At US$166, Is It Time To Put Insulet Corporation (NASDAQ:PODD) On Your Watch List?
May 12Is Insulet (NASDAQ:PODD) A Risky Investment?
Apr 29Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Apr 14Estimating The Fair Value Of Insulet Corporation (NASDAQ:PODD)
Mar 31Insulet: Insulating Patients, Investors Still Have To Wait
Mar 28Insulet (NASDAQ:PODD) Is Doing The Right Things To Multiply Its Share Price
Feb 19Is Insulet Corporation (NASDAQ:PODD) Potentially Undervalued?
Jan 22Insulet: An Interesting, Yet Expensive, Story
Jan 10Is Insulet (NASDAQ:PODD) Using Too Much Debt?
Jan 09Insulet Corporation's (NASDAQ:PODD) Earnings Haven't Escaped The Attention Of Investors
Dec 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$421m |
| Jun 30 2024 | n/a | n/a | US$395m |
| Mar 31 2024 | n/a | n/a | US$234m |
| Dec 31 2023 | US$12m | US$842k | US$206m |
| Sep 30 2023 | n/a | n/a | US$120m |
| Jun 30 2023 | n/a | n/a | US$63m |
| Mar 31 2023 | n/a | n/a | US$600k |
| Dec 31 2022 | US$11m | US$440k | US$5m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$35m |
| Mar 31 2022 | n/a | n/a | US$45m |
| Dec 31 2021 | US$290k | n/a | US$17m |
| Sep 30 2021 | n/a | n/a | -US$29m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | US$9m |
| Dec 31 2020 | US$259k | n/a | US$7m |
| Sep 30 2020 | n/a | n/a | US$29m |
| Jun 30 2020 | n/a | n/a | US$18m |
| Mar 31 2020 | n/a | n/a | US$5m |
| Dec 31 2019 | US$261k | n/a | US$12m |
Compensation vs Market: Jim's total compensation ($USD12.38M) is about average for companies of similar size in the US market ($USD12.86M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Hollingshead (61 yo)
2.5yrs
Tenure
US$12,379,765
Compensation
Dr. James R. Hollingshead, also known as Jim, Ph.D. had been President of Sleep & Respiratory Care Business at ResMed Inc. since July 2020 until May 05, 2022 and served as its President of Sleep Business s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$12.38m | 0.025% $ 4.6m | |
| Group VP | 5.7yrs | US$1.44m | 0.0049% $ 899.2k | |
| Senior VP & CTO | 1.4yrs | US$2.37m | 0.014% $ 2.6m | |
| Senior VP & General Counsel | 5.8yrs | US$2.47m | 0.021% $ 4.0m | |
| Executive VP | 6.8yrs | US$3.14m | 0.018% $ 3.3m | |
| Executive VP | less than a year | no data | 0.00014% $ 25.8k | |
| Senior Vice President of Global Operations | 1.9yrs | no data | 0.0052% $ 962.0k | |
| Senior Director of Investor Relations | less than a year | no data | no data | |
| Senior VP of Regulatory Affairs | 2yrs | no data | 0.0044% $ 818.0k | |
| Senior Director of Corporate Communications | no data | no data | no data | |
| Senior Vice President of Sales & Customer Care | 9.9yrs | no data | no data | |
| Senior VP of Strategy & Corporate Development | less than a year | no data | no data |
2.0yrs
Average Tenure
50.5yo
Average Age
Experienced Management: PODD's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.4yrs | US$12.38m | 0.025% $ 4.6m | |
| Independent Director | 2.8yrs | US$322.50k | 0.0040% $ 731.2k | |
| Independent Chairman | 10.3yrs | US$387.10k | 0.042% $ 7.7m | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Educator Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.1yrs
Average Tenure
61yo
Average Age
Experienced Board: PODD's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 19:25 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Insulet Corporation is covered by 58 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| Jeffrey Johnson | Baird |
| null null | Baird |